Betty Y. Law-Kwan
Dr. Neher's Biophysics Laboratory For Innovative Drug Discovery, State Key Laboratory Of Quality Research In Chinese Medicine
Macao, China
Macao, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Medicinal seahorses (Hippocampus spp.) for Alzheimer's disease within species conservation framework: an integrated review of ethnopharmacology, bioactivity, bibliometrics, and network pharmacology.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 17, 2026
Corrigendum to "TREX1 activators: A novel therapeutic strategy for rheumatoid arthritis management via cfDNA clearance" [Pharmacol. Res. 218 (2025) 107817].
Journal: Pharmacological research
Published: January 13, 2026
KLHL20 alleviates high glucose-induced mitochondrial apoptosis in renal tubular cells by targeting DAPK1 for ubiquitination and degradation.
Journal: Biochemical and biophysical research communications
Published: January 11, 2026
A furanochromone derivative, visnagin stimulates melanogenesis via the activation of cAMP/PKA/CREB pathway.
Journal: European journal of pharmacology
Published: December 09, 2025
Modulating GRP75 to restore calcium homeostasis: a novel neuroprotective strategy of CRSE6# in Parkinson's disease models.
Journal: Journal of advanced research
Published: December 09, 2025
A Furanochromone Derivative, Visnagin stimulates melanogenesis via the activation of cAMP/PKA/CREB Pathway.
Journal: European journal of pharmacology
Published: December 09, 2025
Morin enhances the renoprotective effects of Empagliflozin in diabetic kidney disease via targeting ATF6-DAPK1 signaling.
Journal: Chinese journal of natural medicines
Published: August 12, 2025
OGG1-driven pathogenesis in Kawasaki disease: Identification and pharmacological regulation of a molecular marker validated in transgenic mice and clinical models.
Journal: Pharmacological research
Published: July 18, 2025
TREX1 activators: A novel therapeutic strategy for rheumatoid arthritis management via cfDNA clearance.
Journal: Pharmacological research
Published: April 18, 2025
Ciliatoside A attenuates neuroinflammation in Alzheimer's disease by activating mitophagy and inhibiting NLRP3 inflammasome activation.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 06, 2024
The role of IL-1 family cytokines in diabetic cardiomyopathy.
Journal: Metabolism: clinical and experimental
Published: August 30, 2024
FBXL16: a new regulator of neuroinflammation and cognition in Alzheimer's disease through the ubiquitination-dependent degradation of amyloid precursor protein.
Journal: Biomarker research
Published: July 26, 2024
Last Updated: 09/26/2026